Mexico: Public Health Collapse Hits Vulnerable

Mexico's public health safety net has been deteriorating since the AMLO-era financing reforms, with medicine shortages and a rural care gap that widened through 2025 and 2026. The framework matters for asylum internal relocation analysis — where "just relocate to Mexico" arguments depend on assumed public service access that in reality is severely constrained, particularly for chronic illness sufferers and children.[1]

The evidence base draws on the Pan American Health Organization (PAHO), OECD Health Statistics, Mexican National Institute of Public Health (INSP), Colegio de México, Fundar research, and specific reporting on the IMSS-Bienestar transition and post-Seguro Popular framework.

Historical Context

Mexican public health system trajectory over the 21st century.[2]

Pre-2003 — bifurcated system: IMSS (formal workers), ISSSTE (federal workers), state hospitals for uninsured. 2003-2019 — Seguro Popular universal coverage for uninsured population. 2019 — AMLO government abolition of Seguro Popular; replacement by INSABI (Instituto de Salud para el Bienestar). 2022 — INSABI abolition; replacement by IMSS-Bienestar. 2025-2026 — Continuing implementation challenges.

Seguro Popular Abolition Impact

Seguro Popular provided coverage to ~53 million uninsured Mexicans by 2018. Its 2019 abolition and replacement produced documented service gaps.[3]

Transition disruptions in medicine supply. Rural clinic closures. Specialist care access declines. Cancer treatment particularly affected. Pediatric services disrupted.

Medicine Shortages

Medicine shortage crisis persists through 2025-2026.[4]

Documented Shortages

Pediatric cancer medications — persistent since 2019. HIV/AIDS antiretrovirals — periodic shortages. Insulin — regional shortages. Chemotherapy drugs — supply chain disruptions. Psychiatric medications. Rare disease treatments.

Causes

Centralised purchasing (INSABI/IMSS-Bienestar). Anti-corruption drive disrupting supply chains. UN OPS Compras Consolidadas (UNOPS) transition issues. Federal-state coordination challenges.

Rural Care Gap

Rural Mexico faces persistent healthcare access gaps.[5]

Specific Vulnerable Populations

Chronic Illness Sufferers

HIV/AIDS patients depending on continuing antiretroviral supply. Diabetes patients requiring insulin. Cancer patients requiring chemotherapy. Chronic kidney disease patients (particularly rural). Mental health patients requiring medication.

Children

Pediatric cancer particularly affected. Vaccine schedule disruptions. Pediatric specialist care limited outside Mexico City.

Women

Maternal healthcare gaps in rural areas. Reproductive healthcare access restrictions. GBV medical response inadequate.

Elderly

Geriatric specialist services limited. Long-term care essentially absent from public system.

Paposhvili Framework Application

The Paposhvili v Belgium (2016) ECtHR framework governs medical case return risk analysis in UK/EU. Applied to Mexico:[6]

Severe deterioration risk on return. Appropriate treatment availability in receiving country. Chronic illness sufferers face documented supply chain risks. Specialised treatment particularly limited outside Mexico City.

AM (Zimbabwe) Application

AM (Zimbabwe) v SSHD [2020] UKSC 17 applied Paposhvili framework in UK context. Applies to Mexican medical return cases — particularly HIV/AIDS, cancer, complex chronic conditions.[7]

Asylum Implications

Mexican public health system deterioration affects:[8]

1. Internal Relocation Analysis

Mexican asylum applicants where relocation to Mexico is proposed face documented healthcare access barriers. Country expert evidence essential for chronic illness sufferers.

2. Article 3 ECHR Cases

Where return to Mexico would result in severe health deterioration due to treatment unavailability, Article 3 ECHR analysis applies. Paposhvili/AM Zimbabwe framework directly relevant.

3. US Cancellation of Removal

US "exceptional and extremely unusual hardship" analysis for cancellation of removal — chronic illness family members' access to Mexican healthcare relevant to hardship assessment.

4. Child-Specific

Children with chronic conditions or specialised medical needs face compounded barriers on return to Mexico. See our companion US-born children article.

Evidence Framework

PAHO health statistics on Mexico. OECD Health at a Glance data. INSP research reports. Fundar advocacy reports. UN Special Rapporteur on Right to Health reports. Country expert reports — Mexico specialists. Medical expert reports for specific conditions.

Continuing Reforms 2025-2026

IMSS-Bienestar implementation continues with mixed results:

Coverage expansion goals not fully achieved. State-federal coordination continues to face challenges. Medicine supply gradually improving but shortages persist. Rural clinic network partially restored.

Mexico's public health safety net has undergone significant restructuring since 2019 with documented implementation gaps. Chronic illness sufferers, children with specialised needs, and rural populations face particular access barriers. This informs internal relocation analysis and medical return risk cases under Paposhvili/AM Zimbabwe framework.
PAHO Mexico health reports; INSP research

Conclusion

Mexico public health collapse analysis reveals ongoing implementation gaps post-Seguro Popular abolition. Medicine shortages, rural care gap, specialist access barriers persist. Framework informs internal relocation analysis, Paposhvili/AM Zimbabwe medical return risk cases, and US cancellation hardship analysis. See our companion US-born children article, returnee families article, and humanitarian protection article.